2026 Pineapple Bromelain Industry Update: Soaring Demand, Improved Compliance and Growing Dominance of Leading Players
Release Date:
2026-06-09
Author:
Source:
Abstract
The global market for pineapple bromelain will maintain robust growth in 2026. According to data from QYResearch, the market size stood at approximately USD 187 million in 2024 and is projected to exceed USD 220 million in 2026, representing a compound annual growth rate (CAGR) of 8.5% — notably higher than that of conventional food additives. Domestic demand is expanding at an even faster pace, mainly driven by three major sectors: the advancement of registration systems for special medical purpose foods, the upgrading of high-end feed and pet food, and the expanding market of functional health supplements.
On the supply side, there are around 20 large-scale manufacturers worldwide, among which the top six players jointly hold roughly 40% of the market share, indicating rising industry concentration. Ultrafiltration concentration combined with freeze-drying is the mainstream production process. Freeze-dried products feature an enzyme activity retention rate of 85%–92%, making them highly preferred by buyers of pharmaceutical-grade and special medical purpose food-grade products.
In terms of compliance, food-grade pineapple bromelain must strictly comply with GB 1886.174-2016, pharmaceutical-grade products shall meet the requirements of the Chinese Pharmacopoeia (2020 Edition), and feed-grade products are regulated under the Catalogue of Feed Additives issued by the Ministry of Agriculture and Rural Affairs. In 2026, downstream clients have raised stricter requirements on the authenticity of activity labeling, batch-to-batch stability, as well as internal control standards for microorganisms and heavy metals, phasing out products with low enzyme activity and poor compliance.
Looking ahead to the second half of the year, fueled by the continuous expansion of the health industry and recovering overseas orders, products with high purity (≥2000 GDU/g), superior stability and full-track traceability will gain stronger market competitiveness. The industry is stepping into a refined competition stage centered on compliance, quality and professional services.
Recommended Reading
Contact Information
Consultation Phone Number
Email address
Company Address
No. 3, Tianfu Road, Biomedical Industry Base, Daxing District, Beijing
Mobile website
